EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma
Viruses · 2023
DOI: 10.3390/v15091915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Tengteng Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre (CIRC), Shenzhen Hospital of Southern Medical University, Shenzh…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Herpesvirus 4, Human, Epstein-Barr Virus Infections, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, China, President Foundation of the Third Affiliated Hospital, Southern Medical University.
Abstract (Originalsprache)
This study aimed to develop a model using Epstein–Barr virus (EBV)-associated hub genes in order to predict the prognosis of nasopharyngeal carcinoma (NPC). Differential expression analysis, univariate regression analysis, and machine learning were performed in three microarray datasets (GSE2371, GSE12452, and GSE102349) collected from the GEO database. Three hundred and sixty-six EBV-DEGs were identified, 25 of which were found to be significantly associated with NPC prognosis. These 25 genes were used to classify NPC into two subtypes, and six genes (C16orf54, CD27, CD53, CRIP1, RARRES3, and TBC1D10C) were found to be hub genes in NPC related to immune infiltration and cell cycle regulation. It was shown that these genes could be used to predict the prognosis of NPC, with functions related to tumor proliferation and immune infiltration, making them potential therapeutic targets. The findings of this study could aid in the development of screening and prognostic methods for NPC based on EBV-related features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre (CIRC), Shenzhen Hospital of Southern Medical University, Shenzhen 518100, China.
- The Third School of Clinical Medicine, Southern Medical University, Guangzhou 510630, China.
- Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200040, China.
- Department of Laboratory Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.
- Department of Urology, Shenzhen Hospital of Southern Medical University, Shenzhen 518100, China.
ORCID-Profile: Yinggui Yang, Xiaoming Lyu
Förderung
- Guangdong Basic and Applied Basic Research Foundation, China
- President Foundation of the Third Affiliated Hospital, Southern Medical University
Zitieren
APA
Ding, T., Zhang, Y., Ren, Z., Cong, Y., Long, J., Peng, M., Faleti, O. D., Yang, Y., Li, X., & Lyu, X. (2023). EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma. Viruses. https://doi.org/10.3390/v15091915
Vancouver
Ding T, Zhang Y, Ren Z, Cong Y, Long J, Peng M, et al. EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma. Viruses. 2023. doi:10.3390/v15091915
BibTeX
@article{Ding2023,
author = {Ding, Tengteng and Zhang, Yuanbin and Ren, Zhixuan and Cong, Ying and Long, Jingyi and Peng, Manli and Faleti, Oluwasijibomi Damola and Yang, Yinggui and Li, Xin and Lyu, Xiaoming},
title = {EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15091915}
}
EUVIMED